Arterial Effects of Canakinumab in Patients With Atherosclerosis and Type 2 Diabetes or Glucose Intolerance. - Wikidata - awgldk - TriplyDB

Arterial Effects of Canakinumab in Patients With Atherosclerosis and Type 2 Diabetes or Glucose Intolerance.

Arterial Effects of Canakinumab in Patients With Atherosclerosis and Type 2 Diabetes or Glucose Intolerance.

http://www.wikidata.org/entity/Q37338935

about

Inflammatory processes in cardiovascular disease: a route to targeted therapies.Anti-inflammatory drugs as promising cardiovascular treatments.Psoriasis as a human model of disease to study inflammatory atherogenesis.Vascular inflammation and low-density lipoproteins: is cholesterol the link? A lesson from the clinical trials.IL-1β Inhibition in Cardiovascular Complications Associated to Diabetes Mellitus.The CANTOS Trial: One Important Step for Clinical Cardiology but a Giant Leap for Vascular Biology.Anti-interleukin-1 therapy has mild hypoglycaemic effect in type 2 diabetes.Canakinumab and cardiovascular outcomes: results of the CANTOS trial.

P2860

Q38788685-7566FA36-991E-403B-B18C-8A224D1D200F Q39051784-CB8DDA87-B6CB-4810-A635-F64615C91D75 Q39160397-C01C062A-36B8-46C0-BC70-38FF1C7E2115 Q39215606-ABB6739A-7529-45C7-BC8F-1CEBF6774404 Q39403443-8B689176-10F3-4C98-986B-47B250588BA5 Q45069046-755D910C-F2B4-4265-A91C-1E00368D4D9D Q48124011-61594B05-2923-4998-954E-7BDCDC1369FC Q50022369-E49F01D2-5242-4F9A-A004-11AC3FB63A21

P2860

Arterial Effects of Canakinumab in Patients With Atherosclerosis and Type 2 Diabetes or Glucose Intolerance.

http://www.wikidata.org/entity/Q37338935

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on October 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Arterial Effects of Canakinuma ...... abetes or Glucose Intolerance.

@en

Arterial Effects of Canakinuma ...... abetes or Glucose Intolerance.

@nl

type

label

Arterial Effects of Canakinuma ...... abetes or Glucose Intolerance.

@en

Arterial Effects of Canakinuma ...... abetes or Glucose Intolerance.

@nl

prefLabel

Arterial Effects of Canakinuma ...... abetes or Glucose Intolerance.

@en

Arterial Effects of Canakinuma ...... abetes or Glucose Intolerance.

@nl

P1433

Q37338935-D8FAA87C-6D64-4263-927E-5A7BC54F7830

P1476

Q37338935-0DFE3E28-428D-4CBF-A1D9-49ABD5B3A601

P2093

Q37338935-00D7714E-A64A-4EFA-B7A6-CA10E6BB606B

Q37338935-02D9BB8F-A36A-4FF7-838E-84BD283845C6

Q37338935-076CA989-FD3D-4649-8B45-1FCCE4B012CD

Q37338935-09A74E93-6593-4E58-A37D-FF9BFA21EAAC

Q37338935-443638EF-9D24-49AA-933F-0B2740E25FDE

Q37338935-491B9A75-7980-4F2C-8BDF-D5E5FD558B69

Q37338935-7CA621BC-6A5F-4432-B220-F356B9714029

Q37338935-8C82C091-3184-4F6C-B070-F1F03CDE4204

Q37338935-909D7755-DB86-4FAE-B763-948789A4C0F8

Q37338935-A549CA4B-D510-4F41-986F-3E2460133403

P2860

Q37338935-028B9850-1026-4090-91FF-6CB9391D19D7

Q37338935-039312A8-2415-468D-BA66-5109E95BB215

Q37338935-053FB5E3-96B3-4821-BEB0-1B1577B4AC6D

Q37338935-1321379B-2C6C-4737-8C09-71218C25DCC9

Q37338935-191B2A3D-67AC-4F4F-9F95-F4D3B0D6EA73

Q37338935-1AFA9252-7C1F-4F51-8A15-B16F456290B8

Q37338935-39747BA5-02F0-466E-B360-DEC9F0372021

Q37338935-49A788AE-A852-40E2-B724-4AEF3893BC01

Q37338935-4ED7A848-6154-4C86-AB30-8A3E9C23472E

Q37338935-50445881-CA39-4F67-BB47-20C0116B62EA

P304

Q37338935-673D874D-3434-40F6-85B0-A16CAB83624B

P31

Q37338935-9BD8526F-D341-4224-B7CE-4AAB4131E063

P356

Q37338935-BD8D74EB-CEA6-4716-A080-874DE195FA48

P407

Q37338935-36FC4BBF-0ACE-4312-B15C-AB6EECA6C6DA

P433

Q37338935-AC1349E0-68AC-4067-8BB9-88D8BE56FB09

P478

Q37338935-F425CB08-9595-44FD-89C9-C1B40DEFDDFE

P50

Q37338935-07A2B5F2-72A8-4717-8DBA-31B530FB86A6

Q37338935-3C35F0E1-5AB6-4E48-93DE-B04ECE80AB3F

P577

Q37338935-60D19521-154C-447B-AFA6-12B9124FEC06

P698

Q37338935-0635E995-B4F5-4862-BA24-A94DE85E8781

P921

Q37338935-09B5D998-7DD9-4DAA-BF8F-812803475F65

Q37338935-300693e3-c216-42db-ae98-87a407b3038f

Q37338935-6CC96DDD-48B0-498A-95CD-786A4A0FEAB6

P932

Q37338935-46112093-D9AD-429A-B6B4-75BC1B0D4285

P356

J.JACC.2016.07.768

P1433

Journal of the American College of Cardiology

P1476

Arterial Effects of Canakinuma ...... iabetes or Glucose Intolerance

@en

P2093

Alison D Schecter

http://www.w3.org/2001/XMLSchema#string

Craig T Basson

http://www.w3.org/2001/XMLSchema#string

Denise Yates

http://www.w3.org/2001/XMLSchema#string

Eric C Svensson

http://www.w3.org/2001/XMLSchema#string

Jacqueline S Birks

http://www.w3.org/2001/XMLSchema#string

Jean-Claude Tardif

http://www.w3.org/2001/XMLSchema#string

Marc-Alexandre Gingras

http://www.w3.org/2001/XMLSchema#string

Mary Ann McLaughlin

http://www.w3.org/2001/XMLSchema#string

Matthew D Robson

http://www.w3.org/2001/XMLSchema#string

Nadia Alie

http://www.w3.org/2001/XMLSchema#string

P2860

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

Atherosclerosis — An Inflammatory Disease

Contribution of metabolic reprogramming to macrophage plasticity and function

Inflammation in atherosclerosis

Macrophage plasticity and polarization: in vivo veritas

Inflammation and atherosclerosis

NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

Interleukin-1-receptor antagonist in type 2 diabetes mellitus

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men

P304

1769-1780

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JACC.2016.07.768

http://www.w3.org/2001/XMLSchema#string

P407

P433

16

http://www.w3.org/2001/XMLSchema#string

P478

68

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27737744

http://www.w3.org/2001/XMLSchema#string

P921

atherosclerosis

type-2 diabetes

P932

5064025

http://www.w3.org/2001/XMLSchema#string